GSK3B and early-onset autosomal dominant Alzheimer disease: Moreover, it is not reported whether and how glycogen synthase kinase‐3β (GSK‐3β), a crucial kinase in insulin resistance and Alzheimer disease‐like pathologies, play a role in linking ApoE ε4 and cognitive impairment.